Dementia with Lewy bodies and Alzheimer's disease: Differential diagnosis by cardiac sympathetic innervation MIBG imaging;Demencia con cuerpos de Lewy y enfermedad de Alzheimer: Diagnóstico diferencial mediante estudio de la inervación simpática cardíaca con MIBG

Revista Espanola de Medicina Nuclear

Volumn 25, Issue 4, 2006, Pages 229-235

  Estorch, M ^a,b   Camacho, V ^a   Fuertes, J ^a   Rodriguez Revuelto A ^a   Hernandez M A ^a   Flotats, A ^a   Kulisevsky, J ^a   Carrio I ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Alzheimer's disease; Cardiac MIBG imaging; Cardiac sympathetic innervation; Dementia with Lewy bodies

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 131; NEUROLEPTIC AGENT; TRACER;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIFFERENTIAL DIAGNOSIS; FEMALE; HEALTH CARE UTILIZATION; HEART DENERVATION; HUMAN; LEWY BODY; MALE; MEDICAL ASSESSMENT; PSYCHOSIS; THORAX RADIOGRAPHY;

EID: 33746966040     PISSN: 02126982     EISSN: None     Source Type: Journal    
DOI: 10.1157/13090655     Document Type: Article

References (31)

1. McKeith I, Mintzer J, Aarsland D, Burn D, Chiu H, Cohen-Mansfield J, et al. Dementia with Lewy bodies. Lancet Neurol. 2004;3:19-28.
2. McKeith IG, Galasko D, Kosaka K, Perry EK, Dickson DW, Hansen LA, et al. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology. 1996;47:1113-24.
3. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 1984;34:939-44.
4. Luis CA, Barker WW, Gajaraj K, Harwood D, Petersen R, Kashuba A, et al. Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy-verified sample. Int J Geriatr Psychiatry. 1999;14:526-33.
5. 123I-β-CIT single-photon emission tomography in dementia of the Alzheimer-type and diffuse Lewy body disease. Eur J Nucl Med. 1997;24:320-5.
6. Ishii K, Imamura T, Sasaki M, Yamaji S, Sakamoto S, Kitagaki H, et al. Regional cerebral glucose metabolism in dementia with Lewy bodies and Alzheimer's disease. Neurology. 1998;51:125-30.
7. Lobotesis K, Fenwick JD, Phipps A, Ryman A, Swann A, Ballard C, et al. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not AD. Neurology. 2001;56:643-9.
8. Pasquier J, Michel B, Brenot-Rossi I, Hasse-Sebbag N, Sauvan R, Gastaut JL. Value of 99mTc-ECD SPET for diagnosis of dementia with Lewy bodies. Eur J Nucl Med. 2002;29:1342-8.
9. Shimizu S, Hanyu H, Kanetaka H, Iwamoto T, Koizumi K, Abe K. Differentiation of dementia with Lewy bodies from Alzheimer's disease using brain SPECT. Dement Geriatr Cogn Disord. 2005;20:25-30.
10. 123I- metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease. J Neurol Neurosurg Psychiatry. 1999;67:189-94.
11. Takatsu H, Nishida H, Matsuo H, Watanabe S, Nagashima K, Wada H, et al. Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG. J Nucl Med. 2000;41:71-7.
12. Taki J, Nakajima K, Hwang E-H, Matsunari I, Komai K, Yoshita M, et al. Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. Eur J Nucl Med. 2000;27:566-73.
13. Courbon F, Brefel-Courbon C, Thalamas C, Alibelli MJ, Berry I, Montrastuc J-L, et al. Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease. Mov Disord. 2003;18:890-7.
14. Jimenez-Hoyuela JM, Campos V, Rebollo AC, Gómez JJ, Gutiérrez A. Alteración precoz de la función adrenérgica cardiaca en los parkinsonismos con cuerpos de Lewy. Rev Esp Med Nucl. 2005;24:93-100.
15. 121I] MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's-type and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry. 2001;71:583-81.
16. 123I-meta-iodobenzylguanidine (MIBG) uptake in dementia with Lewy bodies: comparison with Alzheimer's disease. J Neurol Neurosurg Psychiatry. 2001;70:781-3.
17. Oide T, Tokuda T, Momose M, Oguchi K, Nakamura A, Ohara S, et al. Usefulness of [123I]metaiodobenzylguanidine ([123I] MIBG) myocardial scintigraphy in differentiating between Alzheimer's disease and dementia with Lewy bodies. Int Med. 2003;42:686-90.
18. 123I]MIBG myocardial scintigraphy to distinguish between dementia with Lewy bodies and Alzheimer's disease. Eur J Nucl Med Mol Imaging. 2006;33:248-53.
19. 123-Metaiodobenzylguanidine (MIBG) scintigraphy: procedure guidelines for tumour Imaging. Eur J Nucl Med Mol Imaging. 2003;30:BP132-BP9.
20. Folstein MF, Folstein SE, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-98.
21. Estorch M, Carrió I, Berná L, López-Pousa J, Torres G. Myocardial iodine-labeled metaiodobenzylguanidine 123 uptake relates to age. J Nucl Cardiol. 1995;2:126-32.
22. Rahkonen T, Eloniemi-Sulkava U, Rissanen S, Vatanen A, Viramo P, Sulkava R. Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older. J Neurol Neurosurg Psychiatry. 2003;74:720-4.
23. Hamilton RL. Lewy bodies in Alzheimer's disease: a neuropathological review of 145 cases using alpha-synuclein immunohistochemistry. Brain Pathol. 2000;10:378-84.
24. Spillantini MG, Schmidt ML, Lee VM, Trojanowski JQ, Jaques R, Goedert M. α-Synuclein in Lewy bodies. Nature. 1997;388:839-40.
25. McKeith IG, Ballard CG, Perry RH, Ince PG, O'Brien JT, Neill D, et al. Prospective validation of consensus criteria for the diagnosis of dementia with Lewy bodies. Neurology. 2000;54:1050-8.
26. 125I-meta-iodobenzylguanidine accumulation directly caused by 1-methyl-4-phenyl-1,2,3,6-tetrahydroxypyridine, a toxic agent for inducing experimental Parkinson's disease. Nucl Med Commun. 2002;23:161-6.
27. Orimo S, Amino T, Itoh Y, Takahashi A, Kojo T, Uchihara T, et al. Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease. Acta Neuropathol. 2005;109:583-8.
28. McKeith IG, Dickson DW, Lowe J, Emre M, O'Brien JT, Feldman H, et al. Diagnosis and management of dementia with Lewy bodies. Third report of the DLB consortium. Neurology. 2005;65:1863-72.
29. Ballard CG, Jacoby R, Del Ser T, Khan MN, Munoz DG, Holmes C, et al. Neuropathological substrates of psychiatric symptoms in prospectively studies patients with autopsy-confirmed dementia with Lewy bodies. Am J Psychiatry. 2004;161:843-9.
30. Szili-Torok T, Kalman J, Paprika D, Dibo G, Rozsa Z, Rudas L. Depressed baroreflex sensitivity in patients with Alzheimer's and Parkinson's disease. Neurobiol Aging. 2001;22:435-8.
31. Walker Z, Costa DC, Walker RWH, Shaw K, Gacinovic S, Stevens T, et al. Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand. J Neurol Neurosurg Psychiatry. 2002;73:134-40.